Apotex Pharmachem Inc.
Records under this name other than patents Apotex Pharmachem Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Apotex Pharmachem Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,709,634 | Amorphous Form of Rifaximin and Processes for Its Preparation Formerly held In force · High confidence | In force | High confidence | |
| US 7,816,355 | Processes for the Preparation of Rivaroxaban and Intermediates Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 8,101,609 | Processes for the Preparation of Rivaroxaban and Intermediates Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 8,435,989 | Processes for the Preparation of Rivaroxaban and Intermediates Thereof Formerly held Lapsed on the fee record Ended May 7, 2025 · High confidence | Lapsed on the fee record | Ended May 7, 2025 | High confidence |
| US 9,533,949 | Processes for the preparation of 3-alkyl indoles Formerly held Lapsed on the fee record Ended Jan 3, 2025 · USPTO record | Lapsed on the fee record | Ended Jan 3, 2025 | USPTO record |
| US 8,309,547 | Processes for the Preparation of Rivaroxaban and Intermediates Thereof Lapsed on the fee record Ended Nov 13, 2024 · High confidence | Lapsed on the fee record | Ended Nov 13, 2024 | High confidence |
| US 9,382,272 | Methods of Making Lubiprostone and Intermediates Thereof Lapsed on the fee record Ended Jul 5, 2024 · High confidence | Lapsed on the fee record | Ended Jul 5, 2024 | High confidence |
| US 8,471,011 | Preparation of acid addition salts of amine bases by solid phase—gas phase reactions Lapsed on the fee record Ended Jun 25, 2021 · USPTO record | Lapsed on the fee record | Ended Jun 25, 2021 | USPTO record |
| US 7,485,754 | Efficient method for preparing 3-aryloxy-3-arylpropylamines and their optical stereoisomers Lapsed on the fee record Ended Feb 3, 2021 · USPTO record | Lapsed on the fee record | Ended Feb 3, 2021 | USPTO record |
| US 9,359,374 | Polymorphic forms of rifaximin Lapsed on the fee record Ended Jun 7, 2020 · USPTO record | Lapsed on the fee record | Ended Jun 7, 2020 | USPTO record |